In this Viewpoint, Williamsonet al. highlight the distinction between genetic research and clinical testing in Alzheimer's disease. They consider how neurologists can bridge the gap between scientific advances and patient management, helping patients and their families to navigate this complex territory.
- Jennifer Williamson
- Jill S Goldman
- Richard Mayeux